RICHELDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.547
EU - Europa 6.163
AS - Asia 2.124
SA - Sud America 75
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 16
Totale 23.983
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.483
GB - Regno Unito 2.360
IT - Italia 1.262
SE - Svezia 767
CN - Cina 753
SG - Singapore 545
DE - Germania 507
UA - Ucraina 475
TR - Turchia 280
HK - Hong Kong 274
FI - Finlandia 264
FR - Francia 166
BG - Bulgaria 165
IN - India 73
CA - Canada 51
RU - Federazione Russa 50
BR - Brasile 49
ID - Indonesia 46
BE - Belgio 30
KR - Corea 29
VN - Vietnam 28
IR - Iran 22
NL - Olanda 22
NG - Nigeria 20
ZA - Sudafrica 20
IE - Irlanda 15
PK - Pakistan 15
IQ - Iraq 14
AU - Australia 13
EU - Europa 13
CH - Svizzera 10
MX - Messico 10
MY - Malesia 10
PL - Polonia 9
AL - Albania 8
ES - Italia 8
JP - Giappone 8
TW - Taiwan 8
CL - Cile 6
LT - Lituania 6
TH - Thailandia 6
CO - Colombia 5
CZ - Repubblica Ceca 5
PE - Perù 5
RO - Romania 5
AT - Austria 4
BD - Bangladesh 4
EC - Ecuador 4
GR - Grecia 4
HR - Croazia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
BO - Bolivia 2
BZ - Belize 2
DK - Danimarca 2
MG - Madagascar 2
OM - Oman 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BY - Bielorussia 1
EE - Estonia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 23.983
Salva come PNG Salva come JPEG
Città #
Fairfield 2.176
Southend 2.014
Santa Clara 1.538
Woodbridge 1.472
Houston 1.133
Ashburn 1.102
Jacksonville 955
Chandler 921
Seattle 813
Dearborn 752
Wilmington 707
Ann Arbor 696
Cambridge 690
Nyköping 452
Singapore 400
Hong Kong 268
Beijing 234
San Diego 191
Modena 184
Princeton 172
Sofia 164
Eugene 158
Izmir 123
New York 109
Helsinki 107
London 71
Milan 66
Shanghai 58
Des Moines 57
Naples 51
Palermo 50
Redwood City 49
Bremen 46
Rome 45
Boardman 34
Jakarta 33
Brussels 30
Norwalk 28
Phoenix 28
Dong Ket 26
Hefei 26
Frankfurt am Main 25
Guangzhou 23
Florence 22
Turin 21
Bari 20
Kunming 20
Falls Church 19
San Mateo 19
Leawood 17
San Francisco 17
Chicago 15
Nanjing 15
Philadelphia 15
Jinan 14
Bologna 13
Dublin 13
Indiana 13
Kilburn 13
Mountain View 13
Verona 13
Hounslow 12
Toronto 12
Chennai 11
Los Angeles 11
Mumbai 11
Lagos 10
Nanchang 10
Ottawa 10
Pescara 10
Wuhan 10
Chiswick 9
Holly 9
Seongnam 9
Lahore 8
Lucca 8
San Jose 8
Tirana 8
Zhengzhou 8
Moscow 7
Napoli 7
Perugia 7
Pistoia 7
Saint Petersburg 7
Seoul 7
Andover 6
Auburn Hills 6
Bandung 6
Basrah 6
Catania 6
Chongqing 6
Dallas 6
Durban 6
Hangzhou 6
Lusciano 6
Paris 6
Pioltello 6
Rimini 6
Washington 6
Abuja 5
Totale 18.874
Salva come PNG Salva come JPEG
Nome #
Malattie infiltrative diffuse del polmone 842
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 684
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 324
Non-steroid agents for idiopathic pulmonary fibrosis 282
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 275
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 244
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 242
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 236
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 234
Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient 227
Atypical lipomatous tumour (lipoma-like well-differentiated liposarcoma) arising in a pulmonary hamartoma and clinically presenting with pneumothorax 223
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 222
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 218
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts 217
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis 217
Aortic pulse wave velocity measurement in systemic sclerosis patients. 215
Rifabutin for treating pulmonary tuberculosis. 214
A culture-proven case of community-acquired Legionella pneumonia apparently classified as nosocomial: diagnostic and public health implications 211
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 203
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 200
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis 198
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 197
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 197
Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis. 196
Amyotrophic lateral sclerosis and sarcoidosis: a difficult differential diagnosis. 196
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 193
A quantitative proteomic approach to identify significantly altered protein networks in the serum of patients with lymphangioleiomyomatosis (LAM) 193
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 193
Unexpected identification of bilateral masses in an asymptomatic heavy smoker. 192
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis 191
Pulmonary fibrosis and the many faces of UIP 191
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 188
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials 186
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 184
Novel drug targets for idiopathic pulmonary fibrosis 182
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 181
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 181
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. 180
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 179
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. 179
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 177
Management of Idiopathic Pulmonary Fibrosis 176
Smoking-related interstitial lung disease 174
Emerging drugs for idiopathic pulmonary fibrosis. 173
Management of idiopathic pulmonary fibrosis. 173
Sarcoidosis: challenging diagnostic aspects of an old disease. 172
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 172
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 170
Prevalence and prognosis of unclassifiable interstitial lung disease 168
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 167
The big clinical trials in idiopathic pulmonary fibrosis. 167
Macrolides in the treatment of asthma and cystic fibrosis 164
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias 164
MOLECULAR DIAGNOSIS OF TUBERCULOSIS 163
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 160
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. 159
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 158
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 158
Treating idiopathic pulmonary fibrosis: current opportunities and future challenges. 157
Immunomodulatory agents for idiopathic pulmonary fibrosis. 156
Idiopathic pulmonary fibrosis: current challenges and future perspectives 156
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. 155
Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good 155
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 154
Genetic testing in diffuse parenchymal lung disease 153
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 153
Role of the quantiferon-TB test in ruling out pleural tuberculosis: a multi-centre study. 153
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis 152
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 151
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis 151
The role of biomarkers in low respiratory tract infections. 150
Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program. 149
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 149
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis. 148
Identification Of Potential Candidate Biomarkers In Lymphangioleiomyomatosis Using ITRAQ Proteomic Technology 146
To BAL or not to BAL: is this a problem in diagnosing IPF? 145
Early diagnosis of subclinical multi drug-resistant tuberculosis 143
Inappropriatezza prescrittiva dell'ossigenoterapia domiciliare a lungo termine 143
Screening dell’infezione tubercolare latente in operatori sanitari con QuantiFERON-TB e test cutaneo tubercolinico [Screening of latent tuberculosis infection in health care workers by QuantiFERON-TB and tuberculin skin test] 143
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. 142
The complex interrelationships between chronic lung and liver disease: a review. 141
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. 140
HLA-DPB1 Glutamate 69: a genetic marker of beryllium disease 139
Il cloroformio nell'aria alveolare di frequentatori di piscine coperte. 139
Churg-Strauss syndrome in a case of asthma 139
Interferon gamma assays for tuberculosis 138
Immunogenetic basis of environmental lung disease: lessons from the berylliosis model 138
An update on the diagnosis of tuberculosis infection 138
Tubercolosi 138
Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice 138
Idiopathic pulmonary fibrosis: recent trials and current drug therapy 138
Macrolides for chronic asthma. 136
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 136
Tuberculosis infection in foreign-born children: a screening survey based on skin and blood testing. 135
Challenges in idiopathic interstitial lung disease 135
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial 135
Tuberculosis diagnostic tests: Sensitivity, specificity, and comparing apples with apples 134
Interaction of genetic and exposure factors in the prevalence of berylliosis 130
Mycobacterium tuberculosis induces CCL18 expression in human macrophages 130
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases 129
Totale 18.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.555 0 0 0 0 0 839 921 521 519 190 302 263
2020/20213.561 347 180 355 291 366 262 292 444 165 417 243 199
2021/20222.903 86 488 275 221 59 87 200 108 293 208 525 353
2022/20232.694 324 274 169 241 317 402 47 292 331 81 116 100
2023/20242.023 62 129 124 173 372 244 245 244 67 47 128 188
2024/20252.558 212 90 84 417 1.236 519 0 0 0 0 0 0
Totale 24.178